Your browser doesn't support javascript.
loading
Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRD.
Williamson, David; Turkoz, Ibrahim; Wajs, Ewa; Singh, Jaskaran B; Borentain, Stephane; Drevets, Wayne C.
Afiliação
  • Williamson D; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
  • Turkoz I; Department of Psychiatry and Health Behavior at Augusta University, Augusta, Georgia, USA.
  • Wajs E; Department of Statistics and Decision Sciences, Janssen Research & Development, LLC, Titusville, New Jersey, USA.
  • Singh JB; Department of Neuroscience, Janssen Research & Development Belgium, Beerse, Belgium.
  • Borentain S; Neurocrine Biosciences, San Diego, California, USA.
  • Drevets WC; Department of Neuroscience, Janssen Research & Development, LLC, San Diego, California, USA.
Int J Neuropsychopharmacol ; 26(3): 198-206, 2023 03 22.
Article em En | MEDLINE | ID: mdl-36525338
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Transtorno Depressivo Resistente a Tratamento / Ketamina Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Transtorno Depressivo Resistente a Tratamento / Ketamina Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article